TripleHelix Science™ develops investigational gene therapy and biotechnology platforms.
Technologies described on this Site:
- May be in research, preclinical, or clinical development stages
- May not be approved by regulatory authorities
- May never receive regulatory approval
- May not be commercially available
Any references to disease areas, genetic disorders, or cellular aging relate to research objectives only. No statement on this Site should be interpreted as a claim of safety, efficacy, or regulatory authorization.